injection; the androgen content (testosterone + dihydrotestosterone) of the accessory sex organs was also reduced but the differences were not always significant. Cyproterone acetate treatment from 1 to 10 days resulted in a definitive reduction in the relative weights of all accessory sex organs studied and when injected from 11 to 20 days in epididymis and vas deferens.
When cyproterone acetate was injected after 20 days of age, the inhibition of sexual organ weights was reversible and at adulthood organs were normally developed. Cyproterone acetate treatment induced a high percentage of infertile males only when injected from 1 to 10 days. Spermatogenesis, androgen levels in plasma and accessory sex organs, and sexual behaviour were not affected in sterile males.
These results suggest that the functional development of accessory sex organs can be permanently affected by short-term neonatal exposure to endogenous androgens.
INTRODUCTION
In the course of development of male mice, critical periods of testicular activity, characterized by signifi¬ cant concentrations of circulating androgens, occur during embryonic (Pointis, Latreille & Cedard, 1980) , neonatal and pubertal life (Jean-Faucher, Berger, De Turckheim et al. 1978 . Fetal testicular secretions are responsible for the masculinization of internal and external genital organs (Jost, 1947; Raynaud & Frilley, 1947) and for regression of the mammary gland (Raynaud & Frilley, 1949; Elger & Neumann, 1966; Veyssiere, Jean & Jean, 1974) . During the neonatal period in the male rat, hepatic steroid metabolism (De Moor & Denef, 1968; Gustafsson & Stenberg, 1974) and sexual differentiation of the hypothalamus (Harris, 1964; Swanson & van der Werff ten Bosch, 1964;  Barraclough, 1966) Body ( Seminal vesicles (mg/10 g body wt)
3-9 + 0-2 3-4 + 0-2 49 + 3 53 + 2 reduced in sexual target organs when CA was ad¬ ministered from 1 to 10 days (Fig. 1) ; for the other stages androgen contents were also decreased but the differences were not always significant (Fig. 1) . In the 50-day-old males of the four CA-treated groups androgen contents of accessory sex organs were not affected (Fig. 2) (Boesel, Klipper & Shain, 1980; Blondeau, Baulieu & Robel, 1982) . On the other hand, CA, which prevents translocation of the androgen receptor into the nucleus (Brinkmann et al. 1983) , may also alter the synthesis of androgen-dependent proteins since steroid hormones exert their effects at the level of gene transcription (Chan, Means & O' Malley, 1978 (Brain, Evans & Poole, 1974) and sexual (present results) behaviours were not affected in CA-treated mice. Since spermatozoa acquire fertility during epididymal transit, infertility may be induced by inhibitory effects of CA on biochemical epididymal parameters (Rajalakshmi & Prasad, 1975; Rastogi, Milone, Di Meglio et al. 1979) and/or by alteration of the synthesis of specific proteins involved in sperm maturation (Johnson, 1975; Cameo & Blaquier, 1976; Kohane, Garberi, Cameo & Blaquier, 1979; Brooks & Higgins, 1980) . A change in the seminal vesicle secretion of glycoproteins suggested to occur during sperm maturation (Voglmayr, Fairbanks & Lewis, 1983) may also be involved in the sterility of CAtreated males. Since spermatogenesis, sexual be¬ haviour, androgen levels in plasma, testis, epididymis, vas deferens, and circulating gonadotrophin con¬ centrations were not affected by early CA treatment (Jean-Faucher et al. 1984; present results), the infertility observed suggests that the synthesis by sex accessory glands of biochemical factors involved in sperm maturation might be 'programmed' by andro¬ gens during neonatal life.
